Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece

BACKGROUND: To evaluate the long-term cost-effectiveness of liraglutide versus sitagliptin or exenatide, added to oral antidiabetic drug mono- or combination therapy respectively, in patients with Type 2 diabetes in Greece. METHODS: The CORE Diabetes Model, a validated computer simulation model, was...

Descripción completa

Detalles Bibliográficos
Autores principales: Tzanetakos, Charalampos, Melidonis, Andreas, Verras, Christos, Kourlaba, Georgia, Maniadakis, Nikos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179852/
https://www.ncbi.nlm.nih.gov/pubmed/25245666
http://dx.doi.org/10.1186/1472-6963-14-419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179852/
https://www.ncbi.nlm.nih.gov/pubmed/25245666
http://dx.doi.org/10.1186/1472-6963-14-419

Ejemplares similares